(19)
(11) EP 4 426 293 A1

(12)

(43) Date of publication:
11.09.2024 Bulletin 2024/37

(21) Application number: 22889204.8

(22) Date of filing: 28.10.2022
(51) International Patent Classification (IPC): 
A61K 31/4155(2006.01)
A61K 9/14(2006.01)
A61K 9/48(2006.01)
A61K 47/38(2006.01)
A61K 9/20(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/4155; A61K 9/146; A61K 9/1623; A61K 9/2018
(86) International application number:
PCT/CN2022/128315
(87) International publication number:
WO 2023/078179 (11.05.2023 Gazette 2023/19)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 03.11.2021 US 202163275076 P

(71) Applicant: Beijing InnoCare Pharma Tech Co., Ltd.
Changping District Beijing 102206 (CN)

(72) Inventor:
  • CHEN, Xiangyang
    Beijing 102206 (CN)

(74) Representative: Schüssler, Andrea 
Kanzlei Huber & Schüssler Truderinger Strasse 246
81825 München
81825 München (DE)

   


(54) AMORPHOUS SOLID DISPERSION COMPRISING (S) -1- (1-ACRYLOYLPYRROLIDIN-3-YL) -3- ( (3, 5-DIMETHOXYPHENYL) ETHYNYL) -5- (METHYLAMINO) -1H-PYRAZOLE-4-CARBOXAMIDE